Real-World Cost Effectiveness Comparison Of Symbicort Turbuhaler And Duoresp Spiromax In UK Patients With Asthma Or Chronic Obstructive Pulmonary Disease
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1488
https://www.valueinhealthjournal.com/article/S1098-3015(17)31822-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1341
First Page :
A645
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31822-3&doi=10.1016/j.jval.2017.08.1488